1626
The Association between Breast Carcinoma and
Meningioma in Women
Brian S. Custer, M.P.H.1,2 BACKGROUND.Publishedcasereportsofapossibleassociationbetweenmeningi-
Thomas D. Koepsell, M.D.1 oma and breast carcinoma are not uncommon in the literature. Four published
Beth A. Mueller, Dr.P.H.1,3 analytic studies have addressed this suggested association specifically. Three of
thesestudiesreportedsignificantassociations,withrelativeriskestimatesmostly
1Department of Epidemiology, School of Public between1.5and2.0.Theotherstudyreportedrelativeriskpointestimatesnear1.5,
Health and Community Medicine, University of butconfidenceintervalsincluded1.0.Thecurrentstudywasapopulation-based,
Washington,Seattle,Washington.
retrospective cohort analysis that evaluated the risk of subsequent breast carci-
2Pharmaceutical Outcomes Research and Policy nomainwomenwhowerediagnosedwithmeningiomaandtheriskofsubsequent
Program,SchoolofPharmacy,UniversityofWash- meningiomainwomenwhowerediagnosedwithbreastcarcinoma.
ington,Seattle,Washington. METHODS. The measure of association is the relative risk and is reported as the
3Program in Epidemiology, Division of Public standardizedincidenceratio(SIR).UsingwesternWashingtonStatecancerregistry
Health Sciences, Fred Hutchinson Cancer Re- dataandintercensalpopulationestimatesforwesternWashingtonState,incidence
searchCenter,Seattle,Washington.
rates of second primary tumor were compared between identified meningioma
andbreastcarcinomacohortsandthegeneralpopulationfortheyears1992–1998.
RESULTS.Theriskofbreastcarcinomaafterpatientswerediagnosedwithmenin-
gioma (SIR) was 1.54 (95% confidence interval [95% CI], 0.77–2.75). The risk of
meningiomaafterpatientswerediagnosedwithbreastcarcinomawas1.40(95%CI,
0.67–2.58),andtheriskofmeningiomaafterpatientswerediagnosedwithinvasive
breastcarcinomawas1.64(95%CI,0.79–3.02).Ineachcombinationforagegroups
ages(cid:1)50years,riskswereelevated,buttheconfidenceintervalsincluded1.0.
CONCLUSIONS.Theseresultssuggestthattheriskofmeningiomaamongwomen
whohaveexperiencedbreastcarcinomaandtheriskofbreastcarcinomaamong
womenwhohaveexperiencedmeningiomaareelevatedmoderately.Sharedrisk
factorsmayaccountfortherelativelyweekbidirectionalassociationsseeninthis
andotherstudies.Cancer2002;94:1626–35.©2002AmericanCancerSociety.
DOI10.1002/cncr.10410
KEYWORDS: breast carcinoma, meningioma, incidence, cohort, population-based,
cancerregistry.
Supported by Public Health Service grant CA
60710-06, Risk Factors for Intracranial Meningi- P
ublished case reports as early as 1929 suggested a possible asso-
oma,andbytheCancerSurveillanceSystemofthe
FredHutchinsonCancerResearchCenter,whichis ciationbetweenmeningiomaandbreastcarcinoma.Intheinter-
fundedbycontractN01-CN-67009fromtheSEER veningyears,severalclinicalreportsofpatientswhodevelopedboth
ProgramoftheNationalCancerInstitutewithad- meningiomaandbreastcarcinomahavebeenpublished.Since1980,
ditionalsupportfromtheFredHutchinsonCancer
at least 12 case reports have been published in English language
ResearchCenter.
journals in which 56 individuals with diagnoses of both breast carci-
Addressforreprints:BrianS.Custer,M.P.H.,Phar-
nomaandmeningiomaweredescribed.1–11Before1980,17additional
maceutical Outcomes Research and Policy Pro- patients were reported in English language journals.12 The clinical
gram,SchoolofPharmacy,UniversityofWashing- literaturesuggestsseveralpossiblemechanismstoexplaintheclinical
ton, Box 357630, Seattle, WA 98195; Fax: (206)
reports. One article posited an association based merely on collision
543-3835;E-mail:bcuster@u.washington.edu.
tumorsinwhichamalignanttumor(breastcarcinoma)metastasizes
Received December 12, 2000; revision received to a preexisting benign tumor (meningioma).12 Reports of breast
June13,2001;acceptedNovember6,2001. carcinoma and meningioma in situations where the presence of
©2002AmericanCancerSociety
BreastCarcinomaandMeningioma/Custeretal. 1627
pathologically confirmed collision tumors could not region is the critical region responsible for immortal-
be demonstrated prompted explanations suggesting izing cells, resulting in the most aggressive forms of
that meningioma may result as a direct metastasis of meningioma, yet this region has not been implicated
breast carcinoma. Several case reports described me- in the development of breast carcinoma.15
ningioma as a pathologically confirmed, metastatic Currentgeneticinvestigationsandclinicalreports
productofbreastcarcinoma.1–3However,atleastone appear to assume that an association between breast
case report suggested the opposite relation, with me- carcinoma and meningioma already has been estab-
ningioma preceding and serving as the source for lished. However, the literature includes only six stud-
breast malignancy.4 ies that have sought to quantify the association be-
The clinical literature also has suggested that the tween primary malignancies and meningiomas.17–22
association may not be based on metastatic events Specific consideration of the association between
but,rather,oncommonriskfactors.5Thislineofrea- breastcarcinomaandmeningiomahasbeenreported
soning follows from several pieces of evidence. First, infourstudies(Table1):Threeofthesestudiesfound
both breast carcinoma and meningioma occur much a significant association between the two tu-
morefrequentlyinwomenthaninmen.Second,both mors.17,18,22Theotherstudydidnotfindastatistically
tumors occur more frequently as age increases. In significant association.21
addition, increased tumor growth has been observed Theobjectiveofthecurrentstudywastoquantify
during pregnancy for both meningioma and breast theassociationbetweenbreastcarcinomaandmenin-
carcinoma, suggesting hormone-induced stimula- giomainwomenbyusingpopulation-baseddata.The
tion.13Recenteffortstodeterminesharedgeneticpre- hypotheses tested were 1) that a diagnosis of breast
disposition for these two types of neoplasms have carcinoma places a woman at increased risk for a
provided more information but have neither dis- subsequent diagnosis of primary meningioma and 2)
missed nor supported the reported link between the that a diagnosis of meningioma places a woman at
two tumors. In particular, although the BRCA1 and increased risk for a subsequent diagnosis of primary
BRCA2 genes have been linked to familial and spo- breast carcinoma.
radicformsofbreastcarcinoma,ananalysisofBRCA1
and BRCA2 genes in patients with sporadic meningi- MATERIALS AND METHODS
omashassuggestedthatalterationsoftheBRCA1and This study was a population-based, retrospective co-
BRCA2genesarenotcommonpathogeneticeventsin hort analysis. The study population included all the
the development of meningioma.13 femaleresidentsage(cid:1)15yearswhoresidedinthe13
It is possible that an association between breast countiesofwesternWashingtonState,wheretheCan-
carcinomaandmeningiomamaybeduetoanoverlap cerSurveillanceSystem(CSS)attheFredHutchinson
in the gene-environment interactions necessary for CancerResearchCenter(FHCRC)collectsdataonma-
tumorigenesis. For both tumors, recent research has lignant neoplasms and on some nonmalignant neo-
focusedonlossofheterozygosity(LOH),orthelossof plasms. The study period was 1992–1998. During the
one allele in a tumor cell from a chromosome region study period, the average total population of age-eli-
for which individual normal cells are heterozygous: It gible women in the 13-county area was nearly
isbelievedthatLOHpromotestumorigenesisthrough 1,473,000 women.23
aprocesswherebytheexpressionofthediseaseoccurs Since 1974, CSS has collected data on the inci-
with the loss of the normal (or protective) allele dence, treatment, and outcomes for all patients with
through possible pathways, such as gene-environ- newly diagnosed breast carcinoma. Since 1991, CSS
mentinteractionsorbyenvironmentalcausesalone.14 hascollectedthesamedataforpatientswithprimary
Twochromosomalregions,1p13–p21and22q11– meningioma. CSS data-collection staff members ab-
q13,frequentlyexhibitLOHinbreastcarcinoma,me- stractdataon(cid:1)95%ofpatientswithneoplasms,with
ningioma,andothertypesoftumor.15,16Atleastthree the remaining data abstracted by hospital tumor reg-
tumor suppressor inactivation genes have been iden- istrypersonnel.Diagnosisandtreatmentdataareob-
tifiedonthelongarmofchromosome22.15Observed tained from individual medical and hospital records.
associations between breast carcinoma and meningi- CSSstaffmembersaswellasSurveillance,Epidemiol-
oma may be due to the activation (or inactivation) of ogy, and End Results Program representatives carry
genes in these regions. However, the tumorigenesis out all case-finding and quality-control procedures.24
pathways may diverge for breast carcinoma and me- The tumor registry collects confidential information
ningioma, because other unrelated chromosomal re- and assigns a unique number to each individual that
gions have been proposed as critical events. For ex- includes a sequence code to identify additional neo-
ample, it is hypothesized that the 14q24 to 14q32 plasm diagnoses in the same individual. Follow-up
1628 CANCER March15,2002/Volume94/Number6
TABLE 1
PublishedAssociationsbetweenMeningiomaandBreastCarcinomaorOtherPrimaryMalignancies
Associationexamined Results Reference
Meningiomaandbreastcarcinoma Obs,8;Exp,3.4;O/E,1.76 Schoenbergetal.18(DatafromConnecticutTumor
(P(cid:2)0.05) Registry)
Meningiomathenbreastcarcinoma Obs,11;Exp,9.9;O/E,1.1 Emry22(DatafromLosAngelesCountyCancer
(P(cid:1)0.05) SurveillanceProgram)
Breastcarcinomathenmeningioma Obs,37;Exp,10.5;O/E,3.5 —
(P(cid:2)0.001)
Meningiomathenbreastcarcinoma(all RR,1.54(95%CI,0.97–2.34) Helsethetal.17
women)
Meningiomathenbreastcarcinoma RR,1.92(95%CI,1.02–3.29) Helsethetal.17
(womenage50–64yrs)
Breastcarcinomathenmeningioma(all RR,1.75(95%CI,1.08–2.68) Helsethetal.17
women)
Meningiomathenbreastcarcinoma RR,1.76(95%CI,0.74–2.50) Jacobsetal.21(datafromKansasCancerDataService)
Meningiomaandextraneural OR,3.52(P(cid:2)0.01) Belluretal.20
malignancies
Intracranialtumorsandbreastcarcinoma RR,1.83(95%CI,1.4–2.5) Adamietal.19
(meningiomaaccountedfor54%of
confirmedtumors)
Obs:observed;Exp:expected;O/E:observed/expectedratio;RR:relativerisk;95%CI:95%confidenceinterval;OR:oddsratio.
information is collected annually using data from a meningioma occurred starting in 1991, we decided in
varietyofsources,suchashospitalrecords,theWash- advancetoexclude1991datatoensurethemostcom-
ingtonStateDepartmentofMotorVehicles,theHealth plete ascertainment of each disease for every year of
Care Financing Administration, Washington State the study. Each of these data sets alone was used to
deathrecords,voterregistration,SocialSecurityinfor- determine the number of all primary breast carcino-
mation, and the National Death Index. To protect mas and primary invasive breast carcinomas or pri-
patient privacy, CSS did not provide the day of diag- mary meningiomas, respectively. Using this method,
nosis. Therefore, it was necessary to assume that all two cohorts were defined. The meningioma cohort
diagnosesoccurredonthe15thdayofeachdiagnosis consistedof598womenwhowerediagnosedwithany
month.Exactbirthdates(day,month,andyear)were typeofprimarycentralnervoussystem(CNS)menin-
provided. gioma. Similarly, a breast carcinoma cohort was
This study posed minimal risk to study partici- formed that consisted of 21,551 women who were
pants,becausethecancerregistrydidnotprovidedata diagnosedwithanytypeofprimarybreastcarcinoma.
thatwouldpermitidentificationofindividuals;there- Because of the possibility that more aggressive breast
fore, informed consent was not required by the Insti- tumors may be more likely to result in a subsequent
tutional Review Board (IRB). After FHCRC IRB ap- diagnosis of meningioma, a subcohort consisting of
proval of the study design, two data sets were 18,349womenwhohadbeendiagnosedwithprimary
provided. One contained information for all primary invasive breast carcinoma also was identified.
breast carcinoma diagnoses recorded by the registry To determine the number of women who had
since 1974. The other data set contained all primary diagnoses of both diseases, the original two data sets
meningioma diagnoses recorded by the registry. The were linked using the unique cancer registry number
meningioma data included incidental coding of me- fromwhichtheneoplasmsequencenumberhadbeen
ningioma diagnoses before 1991. If a person was di- removed. In linking the data sets, no restrictions on
agnosed with another primary malignancy and then year of diagnosis were employed, and it was deter-
developed meningioma, then reports of the meningi- mined that 35 women who were recorded in the reg-
oma diagnosis may have been submitted to CSS. Di- istry had diagnoses of both diseases. Subsequently,
agnosesbefore1991arerecordedintheCSSdatabut the data set was restricted to include only those
do not reflect complete surveillance for meningioma women for whom the diagnoses of both primary
and, thus, were not used here. Each data set was breast carcinoma and meningioma occurred within
reducedtoprimarydiagnosesoftherespectivedisease thestudyperiod.Amongthewomenineachofthetwo
between 1992 and 1998. Although ascertainment of cohorts, 24 women had diagnoses of both primary
BreastCarcinomaandMeningioma/Custeretal. 1629
CNSmeningiomaandprimarybreastcarcinomadur- Poissondistributionforthedata.25WecalculatedSIRs
ing1992–1998.Atotalofthreewomenwithconcurrent for meningioma in the breast carcinoma cohort and
diagnoses (defined as diagnoses of both meningioma the invasive breast carcinoma subcohort using the
andbreastcarcinomawithinthesame30dayperiod) same method.
were excluded, because these women would have
contributed to the counts for each disease but would RESULTS
not have contributed any length of time at risk (per- The age distributions for meningioma and for both
son-years)tothedenominatorofeachincidencerate, breast carcinoma diagnoses in the study population
arbitrarily increasing the relative risk estimates. No were consistent with the currently accepted, descrip-
diagnosis of either disease occurred at autopsy. tive epidemiology of both diseases (Table 2). The
Forwomeninthemeningiomacohort,thelength greatest number of diagnoses for each disease oc-
of time at risk (person-years) for breast carcinoma curred in women age 50–80 years, even though they
diagnosiswasmeasuredasthetimefrommeningioma make up a relatively small percentage of the general
diagnosistooneoffourpossibleendpoints:diagnosis population of adult women. The occurrence of both
of breast carcinoma, death, lost to CSS follow-up, or diseasesinthesameindividualwasmostcommonfor
theendofthestudy(December,1998).Similarmeth- womenage(cid:1)65years.Duetotheracedistributionin
ods were used to determine person-years at risk for western Washington State, it was only possible to ex-
women in the breast carcinoma cohort and in the amine associations between meningioma and breast
invasive breast carcinoma subcohort. carcinoma for white women.
To determine the expected number of patients In the study, a total of 24 women were identified
with the relevant second tumor, we calculated popu- withdiagnosesofbothmeningiomaandbreastcarci-
lation rates of primary meningioma, primary breast noma during the years 1992–1998. For 10 of these
carcinoma, and primary invasive breast carcinoma in women, the diagnosis of breast carcinoma occurred
western Washington State women using CSS data for first; for 11 women, the diagnosis of meningioma oc-
1992–1998andusingintercensalpopulationestimates curred first; and, for 3 women, we classified the diag-
provided by the Washington State Department of noses as concurrent (Table 3). For nonconcurrent di-
Health as the population person-years at risk.23 The agnoses, regardless of which diagnosis occurred first,
summationoftheannualintercensalpopulationesti- (cid:1)70%ofthewomenhadthesubsequentdiagnosisat
mates from 1992 through 1998 represents the total least7monthsafterthefirstdiagnosis.Amongwomen
accumulated person-years at risk. Washington State who were diagnosed with meningioma first, the
intercensal population estimates are reported as elapsed time until they were diagnosed with breast
5-year age groups, so we were able to determine cor- carcinoma appeared to peak after approximately 2
responding age group specific incidence rates of all years. For women who were diagnosed first with pri-
diagnoses. marybreastcarcinoma,followedbymeningioma,the
All data cleaning and analyses were performed elapsed time between diagnoses was distributed
using Stata statistical software (release 6.0; Stata Cor- evenly over the 7-year follow-up.
poration,CollegeStation,TX).Themeasureofassoci- The greatest incidence of meningioma or breast
ationwastherelativeriskandisreportedasthestan- carcinomaoccurredinwomenbetweentheagesof50
dardized incidence ratio (SIR). We compared the years and 80 years (Table 4). This relation was most
observednumberofbreastcarcinomasinthegroupof evidentforwomeninthebreastcarcinomacohortand
women who had first been diagnosed with meningi- theinvasivebreastcarcinomasubcohort,inwhomthe
oma to the expected numbers of breast carcinomas incidence rates were greatest between the ages of 50
among women with a diagnosis of meningioma. The years and 79 years. The peak incidence rate for me-
expectednumberofbreastcarcinomasinthemenin- ningiomaorbreastcarcinomainthestudypopulation
gioma cohort was determined by multiplying 5-year occurred in women age 65–79 years.
ageandcalendaryearstrataofperson-yearsatriskby The observed number of breast carcinoma diag-
thecorresponding5-yearagegroupspecificincidence nosesinthemeningiomacohortwas11.0,whereasthe
rates of breast carcinoma in the female population. expected number of breast carcinoma diagnoses was
SIRs were calculated as the ratio of observed to ex- 7.16. These values resulted in an SIR of 1.54 (95%CI,
pectednumbersofbreastcarcinomasusingintercen- 0.77–2.75) for the diagnosis of breast carcinoma in
sal population estimates of women age (cid:1) 15 years adult women after a previous diagnosis of meningi-
livinginthe13countyareaofWashingtonStateasthe oma (Table 5). The risk was greatest among women
standard population. Exact 95% confidence intervals age50–64years;however,theconfidenceintervalsfor
(95%CI) were calculated with the assumption of a all age specific risk estimates included 1.0.
1630 CANCER March15,2002/Volume94/Number6
TABLE 2
CharacteristicsofWomenDiagnosedwithMeningioma,WomenDiagnosedwithBreastCarcinoma,andWomenintheGeneralPopulationfrom
WhichtheDiagnosesArose1992–1998
Bothmeningioma
andbreast
Anymeningioma Anybreast Anyinvasivebreast carcinoma Percentof
diagnosis carcinomadiagnosis carcinomadiagnosis diagnoses general
Characteristic (N(cid:1)598women) (N(cid:1)21,551women) (N(cid:1)18,349women) (N(cid:1)24women) population
(attimeoffirstdiagnosis) (%) (%) (%)a (%) age>15yrsb
Agegroup(yrs)
15–34 32(5.4) 379(1.8) 334(1.8) 0(0) 35.6
35–49 152(25.4) 4818(22.4) 3937(21.5) 2(8.3) 31.4
50–64 158(26.4) 6766(31.4) 5644(30.8) 7(29.2) 16.4
65–79 192(32.1) 7138(33.1) 6178(33.7) 11(45.8) 12.0
80(cid:3) 64(10.7) 2450(11.4) 2256(12.3) 4(16.7) 4.6
Race
White(includes
Hispanic) 424(70.9) 19,786(91.8) 16,941(92.3) 23(95.8) 88.0
Black 19(3.2) 467(2.2) 397(2.2) 0 3.5
Asian/PacificIslands 30(5.0) 739(3.4) 606(3.3) 0 7.1
Other 3(0.5) 143(0.7) 135(0.7) 0 1.4
Unknown 122(20.4) 413(1.9) 270(1.5) 1(4.2) —
Maritalstatus
Single 51(8.5) 1678(7.8) 1411(7.7) — —
Married 277(46.3) 12,153(56.4) 10,172(55.4) — —
Divorced/Separated 47(7.9) 2283(10.6) 1985(10.8) — —
Widowed 112(18.7) 4130(19.1) 3698(20.2) — —
Unknown 111(18.6) 1319(6.1) 1083(5.9) — —
aPathologicclassificationoftumortypewasaccordingtotheInternationalClassificationofDiseasesforOncology,secondedition,1990.26
bGeneralpopulationpercentagewerebasedonWashingtonStateintercensalestimates1992–1998(thoseage(cid:2)15yearsaccountfor21.5%ofthetotalpopulation).
The overall estimate of the risk of a diagnosis of collected. Therefore, western Washington State CSS
meningioma in women with a previous diagnosis of data allowed for a population-based investigation of
any breast carcinoma was 1.40 (95% CI, 0.67–2.58) whether women who develop either primary menin-
(Table6).Exceptforwomenage(cid:2)34years,thepoint giomaorprimarybreastcarcinomahaveanincreased
estimates for the age group specific risk of meningi- risk of developing the other disease. Case reports of
oma indicated elevated risk, although the confidence separate tumors occurring in combination are fre-
intervals were quite large and indicated that the re- quent,anditisdifficulttoknowwhethertheseoccur-
sultswerenotstatisticallysignificant.Eventhoughthe rencesarerandomeventsorrepresentanassociation
observedandexpectednumbersofmeningiomadiag- between the tumors.27 In this study, the overall rela-
noses were small for each age group, there was a tive risk point estimates ranged from 1.40 to 1.64.
suggestion of increasing risk in older age groups. However, our results did not indicate statistically sig-
Whentheanalysiswasrestrictedtowomenwithinva- nificant associations between the risk of meningioma
sive breast carcinoma, the risk of a subsequent diag- inwomenwhowerediagnosedpreviouslywithbreast
nosisofmeningiomaincreasedfrom1.40to1.64(95% carcinoma or the risk of breast carcinoma in women
CI, 0.79–3.02) (Table 7). Moreover, each age group who were diagnosed previously with meningioma.
specificestimateforwomenage(cid:1)34yearsincreased, Data collection for this study occurred at a time
and the increased risk at older ages was maintained. when the use of advanced imaging techniques (com-
Once again, although all age specific point estimates puted tomography and magnetic resonance imaging)
were elevated, the confidence intervals included 1.0. was increasingly common. The use of these imaging
techniques has the potential to introduce bias, be-
DISCUSSION cause asymptomatic tumors are more likely to be di-
The CSS registry in Washington State is unique, in agnosed, especially in persons with previously diag-
that, since 1991, data on the population incidence of nosed disease. Information bias that results when
the usually benign tumor, meningioma, have been womenwhohavebeendiagnosedwithonediseaseare
BreastCarcinomaandMeningioma/Custeretal. 1631
TABLE 3
CharacteristicsofWomenDiagnosedwithBothMeningiomaandBreastCarcinoma1992–1998
Bothmeningioma Meningioma Breastcarcinoma
andbreast diagnosedfirst diagnosedfirst Concurrent
carcinoma followedby followedby meningiomaand
diagnoses breastcarcinoma meningioma breastcarcinoma
Characteristic (N(cid:1)24women) (N(cid:1)11women) (N(cid:1)10women) (N(cid:1)3women)
(attimeoffirstdiagnosis) (%) (%) (%) (%)
Agegroup(yrs)
15–34 0(0) 0 0 0
35–49 2(8.3) 1(9) 1(10) 0
50–64 7(29.2) 5(45.5) 2(20) 0
65–79 11(45.8) 5(45.5) 5(50) 1(33.3)
80(cid:3) 4(16.7) 0 2(20) 2(66.7)
Race
White(includes
Hispanic) 23(95.8) 10(91) 10(100) 3(100)
Black 0 0 0 0
Asian/PacificIslands 0 0 0 0
Other 0 0 0 0
Unknown 1(4.2) 1(9) 0 0
Maritalstatus
Single 2(8.3) 1(9.1) 0 0
Married 7(29.2) 3(27.3) 5(50) 0
Divorced/separated 4(16.7) 3(27.3) 1(10) 1(33.3)
Widowed 8(33.3) 2(18.2) 4(40) 2(66.7)
Unknown 3(12.5) 2(18.2) 0 0
TABLE 4
PopulationIncidenceofMeningioma,BreastCarcinoma,andInvasiveBreastCarcinoma
Meningioma Breastcarcinoma Invasivebreastcarcinoma
Age
group Person Incidenceper Incidenceper Incidenceper
(yrs) years No.ofwomen 100,000 No.ofwomen 100,000 No.ofwomen 100,000
15–34 3,661,164 32 0.9 379 10.4 334 9.1
35–49 3,236,484 152 4.7 4818 149 3937 121
50–64 1,705,669 158 9.3 6766 397 5644 331
65–79 1,236,341 192 15.5 7138 577 6178 500
80(cid:3) 470,415 64 13.6 2450 521 2256 480
Total 10,310,073 598 5.8 21,551 209 18,349 178
followed more closely cannot be ruled out. In addi- accuracy a possible association between breast carci-
tion, if medical monitoring is more intensive when a noma and meningioma occurring many years later.
person is diagnosed with either breast carcinoma or Consistently, we detected an association between
meningioma, then it is expected that otherwise breastcarcinomaandmeningioma,butthestudywas
asymptomatic conditions would be diagnosed more limited by the number of women who experienced
frequently proximate to the first diagnosis. A peak in both tumors The combination of small numbers of
second primary neoplasm diagnosis within the year womenwithbothtumorsandthepotentiallytooshort
afterthefirstdiagnosisdidnotoccurforeitherbreast follow-up may explain the large confidence intervals.
carcinoma or meningioma. Thisstudyalsowaslimitedintheanalysisofspe-
Thetotalperiodforthestudywas84months,and cific directions of disease (meningioma followed by
the diagnosis of subsequent meningioma or breast breast carcinoma and breast carcinoma followed by
carcinoma after this time could not be assessed. Me- meningioma).Thediagnosisofeachdiseasewasused
ningiomasareveryslow-growingtumors.28Thisstudy as the proxy measure of occurrence of the disease.
period may have been insufficient to determine with Withtheavailabledata,therewasnowaytodetermine
1632 CANCER March15,2002/Volume94/Number6
TABLE 5
IncidenceofBreastCarcinomainWomenOriginallyDiagnosedwithMeningioma
Subsequentbreastcarcinoma
Womenwithinitialmeningioma
Age Observedno.of Expectedno.of
group Person-years breast breast Standardizedincidence
(yrs) No. atrisk carcinomas carcinomas ratio(95%CI)
18–34 32 57 0 0.01 0
35–49 152 448 1 0.67 1.50(0.04–8.36)
50–64 158 496 5 1.99 2.51(0.81–5.85)
65–79 192 569 5 3.29 1.52(0.49–3.54)
80(cid:3) 64 228 0 1.20 0
Total 598 1798 11 7.16 1.54(0.77–2.75)
95%CI:95%confidenceinterval.
TABLE 6
IncidenceofMeningiomainWomenOriginallyDiagnosedwithAnyBreastCarcinoma
Womenwithinitialbreastcarcinoma Subsequentmeningioma
Age
group Person-years Observedno.of Expectedno.of Standardizedincidence
(yrs) No. atrisk meningiomas meningiomas ratio(95%CI)
18–34 379 759 0 0.01 0
35–49 4818 12,602 1 0.59 1.69(0.04–9.41)
50–64 6766 20,355 2 1.91 1.05(0.13–3.78)
65–79 7138 22,376 5 3.48 1.44(0.47–3.35)
80(cid:3) 2450 8287 2 1.14 1.76(0.21–6.34)
Total 21,551 64,379 10 7.13 1.40(0.67–2.58)
95%CI:95%confidenceinterval.
TABLE 7
IncidenceofMeningiomainWomenOriginallyDiagnosedwithInvasiveBreastCancerCarcinoma.
Womenwithinitial
invasivebreastcarcinoma Subsequentmeningioma
Age
group Person-years Observedno.of Expectedno.of Standardizedincidence
(yrs) No. atrisk meningiomas meningiomas ratio(95%CI)
18–34 334 665 0 0.01 0
35–49 3937 10,337 1 0.49 2.06(0.05–11.48)
50–64 5644 16,853 2 1.58 1.27(0.15–4.57)
65–79 6178 19,253 5 3.00 1.67(0.54–3.89)
80(cid:3) 2256 7,431 2 1.02 1.96(0.24–7.07)
Total 18,349 54,593 10 6.10 1.64(0.79–3.02)
95%CI:95%confidenceinterval.
whetherthepresenceofmeningiomawasoccultand, calculations were dependent on good ascertainment
thus,whethertheoccurrenceofmeningiomaactually ofvitalstatusafteradiagnosisofeithercondition.To
preceded the occurrence of breast carcinoma in the determinewhethermigrationoutoftheCSSdatacol-
two breast carcinoma cohorts. lection area may have resulted in underestimates of
Another limitation of the current study was the the person-years at risk, we examined U.S. Census
inabilitytoaccountforwomenwhonolongerresided Bureau migration patterns for Washington State. The
inwesternWashingtonState.Theperson-yearsatrisk most recently available migration pattern data cover
BreastCarcinomaandMeningioma/Custeretal. 1633
the time period between 1985 and 1990.29 Among ciently different to indicate a specific pathway of as-
personsage(cid:1)5years,74%residedinthesamecounty sociation. For example, if meningioma is a risk factor
of Washington State, and 84% continued to reside in for the development of breast carcinoma, but not the
Washington State. These statistics include persons of reverse,thenonewouldexpectthattherelativeriskof
allages(cid:1)5years;datarestrictedtoadultpopulations breastcarcinomainthemeningiomacohortwouldbe
werenotavailable.Itseemsreasonabletoassumethat notably larger than the risk of meningioma in the
migrationpatternsarerelatedtoageandthatchildren breast carcinoma cohorts.
andyoungfamiliesconstitutethegreatestpercentage The shared risk factors hypothesis suggests that
ofpersonswhochangeresidence.Forthesereasons,it the tumors are not associated causally. Rather, any
does not appear that migration out of western Wash- associationbetweenthetwotumorsrestsonnonspe-
ington State, especially for older women, was an im- cific mechanisms, such as age, gender, hormone in-
portant influence in our study. duction,andpossiblyotherdemographiccharacteris-
Annual vital status information was collected for ticsthatarecommontobothtumors.Theresultsfrom
68% of the women in the meningioma cohort. The studies by Helseth et al. and Jacobs et al. suggested a
reported mortality rate at follow-up was 23%. The nonspecific mechanism of association.17,21 Jacobs et
mortality cause was not available from the CSS data al. did not find evidence for a statistically significant
unless it was from a neoplastic disease for which the associationfortheriskofbreastcarcinomainwomen
registrycollectsdata.Itisassumedthatthemajorityof who were diagnosed with meningioma (standardized
observedmortalityoccurredasaresultofage.Annual mortalityratio,1.43;95%CI,0.74–2.50).Theestimate
vital status information was collected for 94% of the presented here was similar (SIR, 1.54; 95% CI, 0.77–
women in the breast carcinoma cohort. The reported 2.75). Helseth et al. reported a significant association
mortalityrateatfollow-upwas20%.Weassumedthat between breast carcinoma and meningioma when
allwomencontributedfullytotheperson-timeduring breast carcinoma was diagnosed first (SIR, 1.75; 95%
follow-up unless they were deceased. Succinctly, the CI,1.08–2.68).Theassociationwhenmeningiomawas
follow-upendpointofmortalitywaswellascertained, diagnosed first was nearly significant (SIR, 1.54; 95%
but loss to follow-up due to migration would have CI,0.97–2.34).However,noneoftheagegroupspecific
resulted in an overestimate of the true person-time relativerisksreportedbyHelsethetal.weresignificant
under surveillance for the second tumor; hence, the except for women age 50–64 years who were diag-
SIRswouldbeunderestimated.However,becausethe nosed with meningioma first. Because all of the risk
results suggested moderately elevated risks, loss to estimatesreportedbyHelsethetal.representapprox-
follow-updidnotappeartobeadriveroftheanalytic imately the same level of association regardless of
results. whichdiseasewasdiagnosedfirst,thatstudytendsto
By defining the study period as 1992–1998, we support an association on the basis of shared risk
intended to assess accurately the accumulated per- factors.
son-time at risk. The exclusion of diagnoses that oc- InthestudybyHelsethetal.,9of12meningiomas
curredoutsidethestudyperiodwasnecessarytopre- were incidental findings at autopsy.17 Those tumors
vent bias caused by the accumulation of time at risk did not represent medically evident conditions that
only for those women who had been diagnosed with lead to diagnosis or treatment, and it is possible that
oneofthediseasesandnotforallofthewomenwho the inclusion of such diagnoses at autopsy produced
had been diagnosed with both breast carcinoma and thestatisticallysignificantrelativerisks.Incontrast,all
meningioma. This restriction resulted in a reduction of the meningioma diagnoses in the current study
in the number of women with diagnoses of both dis- were me from living women who contributed to the
easesfrom35womento24women.Thesesmallnum- person-years at risk in the appropriate cohort even if
bers of women had a prominent influence on this they were asymptomatic at the time of diagnosis.
analysis. Although the point estimates suggest an as- Emryfoundalargeincreasedriskofmeningioma
sociation, the 95%CIs represent a large range of pos- inwomenwhowerediagnosedpreviouslywithbreast
sible results. A future analysis using additional data carcinoma (observed/expected ratio, 3.5; P (cid:2) 0.001),
fromothercancerregistriesorthesamedata,butover whereas the risk of breast carcinoma in women who
a larger study period, would be helpful in improving were diagnosed with meningioma was not significant
confidence in the risk estimates. (observed to expected tumor ratio, 1.1; P (cid:1) 0.05).22
The current study adds further evidence to the The Emry study relied on Los Angeles County Cancer
suggestionthat,ifthetwotumorsarerelated,thenitis Surveillance Program (CSP) data: At the time of that
probably only because they share common risk fac- study, CSP data only included incidence of meningi-
tors.Noneoftheriskestimatesreportedhereissuffi- oma and/or breast carcinoma. Follow-up data were
1634 CANCER March15,2002/Volume94/Number6
not available, and it was necessary to model the per- tivelybutiscodedwhenavailable.Wheneitherbreast
son-years at risk using SEER cancer rates for the U.S. carcinomaormeningiomaisdiagnosedfirst,thetreat-
population and estimates of mortality. In our study, mentcodesdonotsuggestthatradiationtreatmentis
follow-updata,includingmortality,wereavailablefor aclearfactorinsubsequentriskofdevelopmentofthe
allindividualswhocontinuedtoresideinWashington othertumor.Ofthe10womenwhohadasubsequent
State, and the population rates for all diseases were diagnosis of meningioma after a diagnosis of breast
determinedusingtheregistrydataandtheintercensal carcinoma, only 4 women were treated with beam
populationestimatesfromwhichthediagnosesarose. radiationduringbreastcarcinomatreatment,whereas
The statistical association between breast carci- 6womenhadnoradiationtreatmentofanykind.This
nomaandmeningiomawasreportedfirstbySchoen- prevalence of beam radiation treatment in women
berg et al., who published an observed to expected whohadbothtumorsisnotsignificantlydifferentthan
estimate of 1.76 (P (cid:2) 0.05).18 In that study, only the for women in the entire breast carcinoma cohort. Of
association between the two diseases was examined, the 11 women who had a subsequent diagnosis of
that is, the diagnosis of either breast carcinoma or breast carcinoma after a diagnosis of meningioma, 2
meningioma followed by the diagnosis of the other women were treated with beam radiation, 6 women
disease was included in the same risk calculation. In hadnoradiationtreatmentofanykind,and3women
addition,theestimatewasbasedonasmallnumberof hadmissinginformation.Thispatternofbeamradia-
observed tumors (8) and expected tumors (3.4), and tion, no radiation, and missing data for women diag-
the results represent one of the few significant asso- nosedwithmeningiomaandsubsequentbreastcarci-
ciations from several comparisons of many different noma is not significantly different than for the entire
tumor combinations. meningioma cohort. The treatment code information
The published case reports of meningioma and doesnotsuggestthatradiationtreatmentisrelatedto
breast carcinoma in the same individual suggest that the subsequent risk of developing these second pri-
the pathologic classification of the first tumor may mary neoplasms.
influence the risk of the occurrence of the second The persistence of case reports on the suggested
tumor. This reasoning seems logical, in that a more association and genetic investigation of the common
aggressive tumor may be more likely to metastasize. tumorigenesis pathways continue. Several case re-
Specifically, the CNS is a common metastatic site for portshavebeenpublishedinthe1990s,withthemost
breast tumors.22 Pathologic confirmation of tumor recent published in 1998.3,5,8,9,11 These case reports
typeiscollectedintheCSSregistry.Ofthe24women implythatasignificantassociationispresent,whereas
forwhomthediagnosesofbreastcarcinomaandme- analyticstudieshaveprovided,atbest,equivocalcon-
ningiomaoccurredduringthestudyperiod,22menin- firmation of the association. Even though it was lim-
giomas were classified as benign (the tumor type was ited by its small sample size, the current study sug-
missing for 2 diagnoses). For the breast carcinoma gests that any such association is probably modest.
diagnoses, 4 women had in situ tumors, 18 women Furtheranalysisusinglargersetsofpopulation-based
hadmalignanttumors,and1womanhadametastatic data that include longer follow-up may be necessary
tumor. These breast carcinoma tumor types in the tofullydetectthisassociation.Sharedriskfactorsmay
women with both diagnoses followed the same gen- account for the relatively week bidirectional associa-
eral distribution that was seen in the entire 21,551- tions seen in this study and in other studies.
member breast carcinoma cohort. Because more ag-
gressivetumorsarenomorecommoninwomenwith
diagnoses of both tumors than in women with only REFERENCES
breast carcinoma or meningioma, the data suggest 1. RubinsteinAB,ScheinM,ReichenthalE.Theassociationof
that tumor type probably is not related to the likeli- carcinoma of the breast with meningioma. Surg Gynecol
hoodofdevelopingofasecondprimaryneoplasmfor Obstet.1989;169:334–336.
2. ZonLI,JohnsWD,StomperPC,etal.Breastcancermeta-
these two diseases.
statictoameningioma.ArchInternMed.1989;149:959–962.
To assess whether the suggested risk factor for
3. Cervoni L, Salvati M, Gagliardi D, Delfini R. Metastasis of
meningioma,radiationtreatment,influencesthelike- breast carcinoma to intracranial meningioma. Neurosurg
lihood of the occurrence of both diseases, we exam- Rev.1994;17:233–236.
ined the treatment information contained in the CSS 4. Mehta D, Khatib R, Patel S. Carcinoma of the breast and
meningioma.Cancer.1983;51:1937–1940.
data base, including the type of surgery and various
5. BonitoD,GiarelliL,FalconieriG,Bonifacio-GoriD,Tomasic
treatment modalities for women with a diagnosis of
G,VielhP.Associationofbreastcancerandmeningioma—
breast carcinoma. Treatment information for women
reportof12newcasesandreviewoftheliterature.Pathol
with a diagnosis of meningioma is not collected ac- ResPract.1993;189:399–404.
BreastCarcinomaandMeningioma/Custeretal. 1635
6. SavoiradoM,LodriniS.Hypodenseareawithinameningi- as a risk factor for other primary malignant diseases. A
oma:metastasisfrombreastcancer.Neuroradiology.1980; nation wide cohort. J Natl Cancer Inst. 1984;73(5):1049–
20:107–110. 1055.
7. BurnsPE,JhaN,BainGO.Associationofbreastcancerwith 20. BellurSN,ChandraV,McDonaldLW.Associationofmenin-
meningioma.Cancer.1986;54:1537–1539. giomas with extraneural primary malignancy. Neurology.
8. Smith-BehnJ.Relationshipbetweenbreastcancerandme- 1979;29:1165–1168.
ningioma.SouthernMedJ.1992;85(2):146–147. 21. JacobsDH,HolmesFF,McFarlaneMJ.Meningiomasarenot
9. MarkopoulosC,SamplisF,GivalosN,GogasH.Association significantly associated with breast cancer. Arch Neurol.
ofbreastcancerwithmeningioma.EurJSurgOncol.1998; 1992;49:753–756.
24(4):332–334. 22. Emry JK. The association between breast cancer and me-
10. Knuckey NW, Stoll J, Epstein MH. Intracranial and spinal ningiomas [master’s thesis]. Los Angeles: University of
meningiomasinpatientswithcarcinoma:casereports.Neu-
SouthernCalifornia,1984.
rosurgery.1989;25(1):112–117.
23. WashingtonStateDepartmentofHealth.Demographicsta-
11. Salvati M, Cervoni L. Association of breast carcinoma and
tistics, 1998 [available from URL: http://www.doh.wa.gov/
meningioma: report of nine new cases and review of the
EHSPHL/CHS/]. Seattle: Washington State Department of
literature.Tumori.1996;82:491–493.
Health,1998.
12. Miller RE. Breast cancer and meningioma. J Surg Oncol.
24. Fred Hutchison Cancer Research Center. Cancer surveil-
1986;31:182–183.
lance system fact sheet. Seattle: Fred Hutchinson Cancer
13. KirschM,ZhuJJ,BlackP.AnalysisoftheBRCA1andBRCA2
ResearchCenter,1998.
genesinsporadicmeningioma.GenesChromosomesCancer.
25. Bailar JC, Ederer F. Significance factors for the ratio of a
1997;20:53–59.
Poisson variable to its expectation. Biometrics. 1964:639–
14. GelehrterTD,CollinsFS,GinsburgD.Principlesofmedical
643.
genetics,2nded.Baltimore:Williams&WilkinsInc.,1998:
26. PercyC,VanHoltenV,MuirC,editors.Internationalclas-
245–272.
sification of diseases oncology, 2nd ed. Geneva: World
15. LeonePE,BelloMJ,deCamposJM,etal.NF2genemuta-
tionsandallelicstatusof1p,14qand22qinsporadicme- HealthOrganization,1990.
ningiomas.Oncogene.1999;18:2231–2239. 27. MoertelCG.Multipleprimarymalignantneoplasms:histor-
16. Allione F, Eisinger F, Parc P. Loss of heterozygosity at loci icalperspectives.Cancer.1977;40:1786–1792.
fromchromosomearm22qinhumansporadicbreastcar- 28. AlvordEC,ShawCM.Neoplasmaffectingthenervoussys-
cinomas.IntJCancer.1998;75:181–186. tem of the elderly. In: Ducket S, ed. The pathology of the
17. Helseth A, Mork SJ, Glattre E. Neoplasms of the central aginghumannervoussystem.Philadelphia:LeaandFebiger
nervoussysteminNorway.APMIS.1989;97:738–744. 1991:210–286
18. SchoenbergBS,ChristineBW,WhisnantJP.Nervoussystem 29. United States Census Bureau. U.S. Census Bureau, 1999
neoplasmsandprimarymalignanciesofothersites.Neurol- [available from URL: http://www.census.gov/population/
ogy.1975;25:705–712. socdemo/migration/net-mig.txt]. Washington, DC: United
19. AdamiHO,BergkvistL,KrusemoU,PerssonI.Breastcancer StatesCensusBureau,1999.
